Sapporo Clinical Laboratory Center, Inc. Financial Overview
Sapporo Clinical Laboratory Center, Inc.'s market cap is currently ¥6.71B. The company's EPS TTM is ¥65.08; its P/E ratio is 12.47; and it has a dividend yield of 1.17%. Sapporo Clinical Laboratory Center, Inc. is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
